DOI:
10.1055/s-00000011
DMW - Deutsche Medizinische Wochenschrift
LinksClose Window
References
Clark GM et al.
Smoking history and epidermal growth factor receptor expression as predictors of survival benefit from erlotinib for patients with non-small-cell lung cancer in the National Cancer Institute of Canada Clinical Trials Group study BR.21.
Clin Lung Cancer 2006;
7: 389-394
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.